Clear Creek Financial Management’s FT Vest US Equity Moderate Buffer ETF March GMAR Stock Holding History

Clear Creek Financial Management’s Portfolio GMAR Stock Details GMAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221K	Buy	+5,000	New	+$218K	0.01%	589

Other funds holding GMAR

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

FIBOI

First International Bank of Israel Tel Aviv $367M AUM 14.87% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

BHC

Bull Harbor Capital Bethesda, Maryland $513M AUM

WTFG

Wood Tarver Financial Group Boise, Idaho $424M AUM 24.33% 1-Year Est. Return

CHC

City Holding Co Charleston, West Virginia $884M AUM 27.52% 1-Year Est. Return

Clear Creek Financial Management's GMAR Position: Q2 2026 in Review

Clear Creek Financial Management opened a new position in FT Vest US Equity Moderate Buffer ETF March (GMAR) in Q2 2026: 5,000 shares worth $221K. The stake represents 0.01% of the portfolio and ranks #589 among its holdings.

127 funds tracked by Wall St. Rank hold GMAR as of Q2 2026.

Clear Creek Financial Management held 5,000 shares of FT Vest US Equity Moderate Buffer ETF March worth $221K as of Q2 2026.
FT Vest US Equity Moderate Buffer ETF March was a new Clear Creek Financial Management position in Q2 2026.
FT Vest US Equity Moderate Buffer ETF March made up 0.01% of Clear Creek Financial Management's portfolio in Q2 2026, its #589 holding.
127 funds tracked by Wall St. Rank held FT Vest US Equity Moderate Buffer ETF March as of Q2 2026.

Based on Clear Creek Financial Management's 13F filing for Q2 2026, filed 28 Jul 2026.